1. Market Research
  2. > Pharmaceutical Market Trends
High Potency APIs Market/HPAPI Market by Type, Type of Synthesis, Manufacturers, Application Region - Global forecast to 2027

High Potency APIs Market/HPAPI Market by Type, Type of Synthesis, Manufacturers, Application Region - Global forecast to 2027

  • May 2022
  • 270 pages
  • ID: 5073744
  • Format: PDF
  • MarketsandMarkets

Summary

Table of Contents

Search Inside

The HPAPI market is projected to reach USD 39.6 Billion by 2027 from USD 24.5 billion in 2022, at a CAGR of 10.1% from 2022 to 2027. The market is driven by increasing demand for oncology drugs, growing demand for antibody-drug conjugates and others.

The innovative HPAPIs segment is expected to account for the largest share of the market in 2021
Based on type, the HPAPI market is segmented into innovative and generic.The innovative segment is expected to account for the largest share of the HPAPI market in 2021.

The large share can be attributed to the increased R&D investments.

The Synthetic APIs segment to account for the largest share of the market in 2021
Based on type of synthesis, the market is segmented into synthetic and biotech HPAPIs.The synthetic APIs segment is expected to command the largest share in 2021.

Ease of production and emergence of new molecules and technological advancements in synthesis are driving growth of synthetic HPAPI segment.

The Oncology segment is expected to account for the largest share of the market in 2021
Based on therapeutica application, the market is divided into oncology, hormonal imbalance, glaucoma, and other therapeutic applications.In 2021, Oncology segment is expected to account for the largest share in the market.

The launch of new target therapies in addition to technological advancements and growing prevalence of cancer across the globe are driving growth of oncology segment.

The Asia region is the fastest growing region of HPAPI market from 2022 to 2027

HPAPI market is segmented into North America, Europe, Asia, and the Rest of the World (RoW).Asia to grow at the highest CAGR during the forecast period.
High prevalence of chronic diseases, lifestyle diseases, age related diseases and government efforts for encouragement for the adoption of generics are some of the factors driving the growth of the market in Asia.

Breakdown of primaries
The study contains insights from various industry experts, ranging from component suppliers to Tier 1 companies and OEMs. The break-up of the primaries is as follows:
•?By Respondent: Supply Side: 70%, Demand Side: 30%
•?By Designation: Managers: 65%, Executives: 25%, and CXOs: 10%
•?By Region: North America: 25%, Europe: 20%, Asia: 45%, and RoW: 10%
Prominent players in the HPAPI market include Pfizer, Inc. (US), F. Hoffmann-La Roche (Switzerland), Sanofi (France), Bristol-Myers Squibb Company (US), Bayer AG (Germany), Novartis International AG (Switzerland), Boehringer Ingelheim International GmbH. (Germany), Teva Pharmaceutical Industries Ltd. (Israel), Eli Lilly and Company (US), Merck & Co., Inc. (US), AbbVie (US), and Viatris Inc. (US).

Research Coverage:
The report segments the HPAPI market based on region (Asia, Europe, North America, and RoW), Type (Innovative, Generic), Type of Synthesis (Biotech, Synthetic), Type of manufacturer (Captive and Merchant), Therapeutic Applications (Oncology, Hormonal Imbalance, Glaucoma). The report also provides a comprehensive review of market drivers, opportunities, restraints, and challenges in the HPAPI market.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants in this market and provide information on the closest approximations of the revenue numbers for the overall HPAPI market and its subsegments.This report will help the stakeholders to understand the competitive landscape, to gain more insights to better position their businesses, and to plan suitable go-to-market strategies.

The report will also help the stakeholders to understand the pulse of the market and provide information on key market drivers, restraints, opportunities, and challenges.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Grace helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Mid-Size Pharmaceutical Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type, Drug Development Type, Formulation, and Therapy Class

  • $ 4550
  • June 2022
  • 203 pages

The mid-size pharmaceutical market is expected to grow from US$ 6,51,349.9 million in 2021 to US$ 10,00,584.3 million by 2028; it is estimated to grow at a CAGR of 6.4% from 2021 to 2028. The increasing ...

  • World
  • APAC
  • Pharmaceutical
  • Light Vehicle
  • Industry analysis
  • Pharmaceutical Revenue
  • Health Expenditure

ref:plp2022

Reportlinker.com © Copyright 2022. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on